
|Articles|July 27, 2020
Adenovirus COVID-19 Vaccines: Challenges of Prior AD Immunity
Author(s)Grant M. Gallagher
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the messenger RNA candidates to the adenovirus vaccines.
Advertisement
Dr. Patrick Soon-Shiong and Dr. Adam Brufsky move on from the
Dr. Soon-Shiong delves into some of his reasoning for the ImmunityBio vaccine candidate's particular orientation toward the immune system.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 1 in 5 Urinary Tract Infections in Southern California Linked to Contaminated Meat
2
High Continued Adherence of Lenacapavir in Individuals Who Use Substances and Alcohol
3
Moderna Discontinues Development of Vaccine for Congenital CMV After Not Meeting Primary Efficacy Endpoint
4
Risk Stratification, Testing, and Treatment in Recurrent Clostridioides difficile
5













































































































































































































































































































